Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Complete Blood Count Device Market Expected To Expand Between 2025 And 2029?
The overall valuation of the complete blood count device sector has experienced robust expansion lately, projected to advance from $4.11 billion in 2024 to reach $4.33 billion by 2025, reflecting a steady compound annual growth rate of 5.4%. This upward trajectory observed during the past period is chiefly driven by several key factors, including the increasing frequency of contagious illnesses, heightened consciousness regarding proactive health measures, the broadening footprint of testing facilities, the proliferation of health evaluation initiatives sponsored by the public sector, and a notable increase in the proportion of elderly individuals within the population.
Anticipation surrounds the complete blood count device sector, projecting substantial expansion in the forthcoming years, with projections indicating the market will reach a valuation of $5.45 billion by 2029, fueled by a compound annual growth rate (CAGR) of 5.9%; this upward trajectory is fundamentally driven by ongoing technological refinements in hematology analysis equipment, the embedding of artificial intelligence and automated processes within diagnostic procedures, heightened consumer need for testing conducted at the point of care, escalating healthcare spending across developing economies, and the increasing incidence of long-term health conditions, while prevailing market currents feature the adoption of AI for interpreting test outcomes, downscaling device size to facilitate point-of-care use, implementation of wireless data transfer functionalities, creation of consumable supplies in cartridge format, and the inclusion of capabilities for running multiple tests simultaneously.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp
What Are The Main Drivers Boosting The Complete Blood Count Device Industry’s Expansion?
The increasing incidence of ailments affecting the blood is anticipated to be a primary catalyst for the expansion of the market for complete blood count instruments going forward. Disruptions in the manufacturing, operation, or composition of blood cells, which lead to compromised blood functionality, define these blood disorders. This escalation in blood-related illnesses correlates with the rising spread of conditions linked to modern living, where suboptimal nutrition, lack of exercise, and elevated stress levels contribute to issues like insufficient clotting or anemia. Diagnostic assistance for these blood disorders is provided by complete blood count (CBC) devices through the examination of crucial blood elements and the identification of anomalies, empowering medical practitioners to pinpoint coagulation disorders and administer timely, accurate care. Illustratively, in May 2024, data released by the Canadian Cancer Society, situated in Canada, indicated that 4,100 people received diagnoses of multiple myeloma, a form of blood malignancy, and tragically, 1,750 fatalities were attributed to the illness. Consequently, the expanding frequency of blood disorders is directly fueling the advancement of the complete blood count device market.
What Are The Major Segment Categories Driving The Complete Blood Count Device Market Growth?
The complete blood count devicemarket covered in this report is segmented –
1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers
2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types
3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy
4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Retail Pharmacies
5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers
2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents
3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits
4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers
Which Market Trends Are Creating New Opportunities In The Complete Blood Count Device Industry?
Leading enterprises within the complete blood count device sector are concentrating their efforts on innovating sophisticated offerings, notably portable hematology analyzers, aiming to deliver diagnostic tools that are more precise, swifter, and budget-friendly specifically for decentralized testing environments. These compact hematology systems represent user-friendly, transportable instruments capable of rapidly producing precise results for complete blood counts (CBC) utilizing only trace amounts of patient sample, thereby rendering them perfectly suited for immediate testing sites, significantly boosting diagnostic reliability, operational quickness, and simplicity of operation, all while maintaining economical operation and straightforward upkeep. As an illustration, in the month of June in 2024, HORIBA, a technology firm specializing in measurement and analysis based in Japan, introduced their new compact hematology analysis units, the Yumizen H550E and H500E. These streamlined units successfully integrate the measurement of erythrocyte sedimentation rate (ESR) alongside both the standard CBC and the five-part differential (DIFF) assessment, leveraging HORIBA’s proprietary CoRA (correlated rouleaux analysis) methodology to furnish thorough diagnostic outputs from whole blood specimens in a mere minute.
Who Are The Top Performing Companies In The Complete Blood Count Device Market In Recent Years?
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Bio-Rad Laboratories, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Ajanta Export Industries, Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report
Which Regional Markets Are Contributing Most To The Complete Blood Count Device Industry Expansion?
North America was the largest region in the complete blood count device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Complete Blood Count Device Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp
Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2025, By The Business Research Company
Continous Blood Glucose Monitoring Global Market Report 2025
Blood Gas And Electrolyte Analyzers Global Market Report 2025
Blood Collection Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model